Is immediate breast reconstruction safe in women over 70? An analysis of the National Surgical Quality Improvement Program (NSQIP) database.


Journal

Breast cancer research and treatment
ISSN: 1573-7217
Titre abrégé: Breast Cancer Res Treat
Pays: Netherlands
ID NLM: 8111104

Informations de publication

Date de publication:
Aug 2019
Historique:
received: 24 04 2019
accepted: 06 05 2019
pubmed: 4 6 2019
medline: 21 12 2019
entrez: 3 6 2019
Statut: ppublish

Résumé

The safety of immediate breast reconstruction (IBR) in older women is largely unknown. This study aimed to determine the 30-day postoperative complication rates following IBR (implant-based or autologous) in older women (≥ 70 years) with breast cancer and to compare them to younger women (18-69 years). The National Surgical Quality Improvement Program (NSQIP) database was used to identify women with in situ or invasive breast cancer who underwent IBR (2005-2016). Outcomes included 30-day postoperative morbidity and mortality, which were compared across age groups stratified by type of reconstruction. Of 28,850 women who underwent implant-based and 9123 who underwent autologous reconstruction, older women comprised 6.5% and 5.7% of the sample, respectively. Compared to younger women, older women had more comorbidities, shorter operative times, and longer length of hospital stay. In the implant-based reconstruction group, the 30-day morbidity rate was significantly higher in older women (7.5% vs 5.3%, p < 0.0001) due to higher rates of infectious, pulmonary, and venous thromboembolic events. Wound morbidity and prosthesis failure occurred equally among age groups. In the autologous reconstruction group, there was no statistically significant difference in the 30-day morbidity rates (older 9.5% vs younger 11.6%, p = 0.15). Both wound morbidity and flap failure rates were similar between the two age groups. For both reconstruction techniques, mortality within 30 days of breast surgery was rare. Immediate breast reconstruction is safe in older women. These data support the notion that surgeons should discuss IBR as a safe and integral part of cancer treatment in well-selected older women.

Identifiants

pubmed: 31154580
doi: 10.1007/s10549-019-05273-1
pii: 10.1007/s10549-019-05273-1
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

215-224

Références

Smith BD, Smith GL, Hurria A, Hortobagyi GN, Buchholz TA (2009) Future of cancer incidence in the United States: burdens upon an aging, changing nation. J Clin Oncol 27:2758–2765
doi: 10.1200/JCO.2008.20.8983 pubmed: 19403886
Biganzoli L, Wildiers H, Oakman C et al (2012) Management of elderly patients with breast cancer: updated recommendations of the International Society of Geriatric Oncology (SIOG) and European Society of Breast Cancer Specialists (EUSOMA). Lancet Oncol 13:e148–e160
doi: 10.1016/S1470-2045(11)70383-7 pubmed: 22469125
Eltahir Y, Werners LL, Dreise MM et al (2013) Quality-of-life outcomes between mastectomy alone and breast reconstruction: comparison of patient-reported BREAST-Q and other health-related quality-of-life measures. Plast Reconstr Surg 132:201e–209e
doi: 10.1097/PRS.0b013e31829586a7 pubmed: 23897347
Atisha D, Alderman AK, Lowery JC, Kuhn LE, Davis J, Wilkins EG (2008) Prospective analysis of long-term psychosocial outcomes in breast reconstruction: two-year postoperative results from the Michigan Breast Reconstruction Outcomes Study. Ann Surg 247:1019–1028
doi: 10.1097/SLA.0b013e3181728a5c pubmed: 18520230
Nano MT, Gill PG, Kollias J, Brochner MA, Malycha P, Winefield HR (2005) Psychological impact and cosmetic outcome of surgical breast cancer strategies. ANZ J Surg 75:940–947
doi: 10.1111/j.1445-2197.2005.03517.x pubmed: 16336382
Oh DD, Flitcorft K, Brennan ME, Spillane AJ (2016) Patterns and outcomes of breast reconstruction in older women—a systematic review of the literature. Eur J Surg Oncol 42:604–615
doi: 10.1016/j.ejso.2016.02.010 pubmed: 26965305
Girotto JA, Schreiber J, Nahabedian MY (2003) Breast reconstruction in the elderly: preserving excellent quality of life. Ann Plast Surg 50:572–578
doi: 10.1097/01.SAP.0000069064.68579.19 pubmed: 12783001
Figueiredo MI, Cullen J, Hwang YT, Rowland JH, Mandelblatt JS (2004) Breast cancer treatment in older women: does getting what you want improve your long-term body image and mental health? J Clin Oncol 22:4002–4009
doi: 10.1200/JCO.2004.07.030 pubmed: 15459224
Godfrey PM, Godfrey NV, Romita MC (1995) Immediate autogenous breast reconstruction in clinically advanced disease. Plast Reconstr Surg 95:1039–1044
doi: 10.1097/00006534-199505000-00013 pubmed: 7732113
Bowman CC, Lennox PA, Clugston PA, Courtemanche DJ (2006) Breast reconstruction in older women: should age be an exclusion criterion? Plast Reconstr Surg 118:16–22
doi: 10.1097/01.prs.0000220473.94654.a4 pubmed: 16816669
Song D, Slater K, Papsdorf M et al (2016) Autologous breast reconstruction in women older than 65 years versus women younger than 65 years: a multi-center analysis. Ann Plast Surg 76:155–163
doi: 10.1097/SAP.0000000000000527 pubmed: 26637165
Johnson DB, Lapin B, Wang C et al (2016) Advanced age does not worsen recovery or long-term morbidity after postmastectomy breast reconstruction. Ann Plast Surg 76:164–169
doi: 10.1097/SAP.0000000000000512 pubmed: 25954837
Sisco M, Johnson DB, Wang C, Rasinski K, Rundell VL, Yao KA (2015) The quality-of-life benefits of breast reconstruction do not diminish with age. J Surg Oncol 111:663–668
doi: 10.1002/jso.23864 pubmed: 25560083
Sabino J, Lucas DJ, Shriver CD, Vertees AE, Valerio IL, Singh DP (2016) NSQIP analysis: increased immediate reconstruction in the treatment of breast cancer. Am Surg 82:540–545
pubmed: 27305887
Hoskin TL, Hieken TJ, Degnim AC, Jakub JW, Jacobson SR, Boughey JC (2016) Use of immediate breast reconstruction and choice for contralateral prophylactic mastectomy. Surgery 159:1199–1209
doi: 10.1016/j.surg.2015.11.001 pubmed: 26704783
Habermann EB, Thomsen KM, Hieken TJ, Boughey JC (2014) Impact of availability of immediate breast reconstruction on bilateral mastectomy rates for breast cancer across the United States: data from the nationwide inpatient sample. Ann Surg Oncol 21:3290–3296
doi: 10.1245/s10434-014-3924-y pubmed: 25052247
Holley DT, Toursarkissian B, Vasconez HC et al (1995) The ramifications of immediate reconstruction in the management of breast cancer. Am Surg 61:60–65
pubmed: 7832384
Wilkins EG, Cederna PS, Lowery JC et al (2000) Prospective analysis of psychosocial outcomes in breast reconstruction: one-year postoperative results from the Michigan Breast Reconstruction Outcome Study. Plast Reconstr Surg 106:1014–1025
doi: 10.1097/00006534-200010000-00010 pubmed: 11039373
Sullivan SR, Fletcher DR, Isom CD, Isik FF (2008) True incidence of all complications following immediate and delayed breast reconstruction. Plast Reconstr Surg 122:19–28
doi: 10.1097/PRS.0b013e3181774267 pubmed: 18594356
Butler PD, Nelson JA, Fischer JP et al (2016) Racial and age disparities persist in immediate breast reconstruction: an updated analysis of 48,564patients from the 2005 to 2011. Am J Surg 212:96–101
doi: 10.1016/j.amjsurg.2015.08.025 pubmed: 26545345
Brennan ME, Spillane AJ (2013) Uptake and predictors of post-mastectomy reconstruction in women with breast malignancy–systematic review. Eur J Surg Oncol 39:527–541
doi: 10.1016/j.ejso.2013.02.021 pubmed: 23498363
In H, Jiang W, Lipsitz SR, Neville BA, Weeks JC, Greenberg CC (2013) Variation in the utilization of reconstruction following mastectomy in elderly women. Ann Surg Oncol 20:1872–1879
doi: 10.1245/s10434-012-2821-5 pubmed: 23263733
Morrow M, Mujahid M, Lantz PM et al (2005) Correlates of breast reconstruction: results from a population-based study. Cancer 104:2340–2346
doi: 10.1002/cncr.21444 pubmed: 16216000
Christian CK, Niland J, Edge SB, Ottesen RA, Hughes ME, Theriault R et al (2006) A multi-institutional analysis of the socioeconomic determinants of breast reconstruction: a study of the National Comprehensive Cancer Network. Ann Surg 243:241–249
doi: 10.1097/01.sla.0000197738.63512.23 pubmed: 16432358 pmcid: 1448910
Alderman AK, McMahon L, Wilkins EG (2003) The national utilization of immediate and early delayed breast reconstruction and the effect of sociodemographic factors. Plast Reconstr Surg 111:695
doi: 10.1097/01.PRS.0000041438.50018.02 pubmed: 12560690
Agarwal S, Pappas L, Neumayer L, Agarwal J (2011) An analysis of immediate postmastectomy breast reconstruction frequency using the Surveillance, Epidemiology, and End Results Database. Breast J 17:352–358
doi: 10.1111/j.1524-4741.2011.01105.x pubmed: 21615823
Reaby LL (1998) Reasons why women who have mastectomy decide to have or not to have breast reconstruction. Plast Reconstr Surg 101:1810–1818
doi: 10.1097/00006534-199806000-00006 pubmed: 9623821
Handel N, Silverstein MJ, Waisman E, Waisman JR (1990) Reasons why mastectomy patients do not have breast reconstruction. Plast Reconstr Surg 86:1118–1125
doi: 10.1097/00006534-199012000-00012 pubmed: 2243854
Howard-McNatt M, Forsberg C, Levine EA, DeFranzo A, Marks M, David L (2011) Breast cancer reconstruction in the elderly. Am Surgeon 77:1640–1643
pubmed: 22273222
Kamali P, Curiel D, van Veldhuisen CL et al (2017) Trends in immediate breast reconstruction and early complication rates among older women: a big data analysis. J Surg Oncol 115:870–877
doi: 10.1002/jso.24595 pubmed: 28409847
Hershman DL, Richards CA, Kalinsky K, Wilde ET, Lu YS, Ascherman JA et al (2012) Influence of health insurance, hospital factors and physician volume on receipt of immediate post-mastectomy reconstruction in women with invasive and non-invasive breast cancer. Breast Cancer Res Treat 136:535–545
doi: 10.1007/s10549-012-2273-4 pubmed: 23053659 pmcid: 3651032
Agarwal S, Kidwell KM, Kraft CT et al (2015) Defining the relationship between patient decisions to undergo breast reconstruction and contralateral prophylactic mastectomy. Plast Reconstr Surg 135:661–670
doi: 10.1097/PRS.0000000000001044 pubmed: 25719688 pmcid: 4822506
August DA, Wilkins E, Rea T (1994) Breast reconstruction in older women. Surgery 115:663–668
pubmed: 8197555
Muss HB (2010) Coming of age: breast cancer in Seniors. Oncologist 15(suppl 5):57–65
doi: 10.1634/theoncologist.2010-S5-57 pubmed: 21138956
Oeffinger KC, Fontham ET, Etzioni R et al (2015) Breast cancer screening for women at average risk: 2015 guideline update from the American Cancer Society. JAMA 314:1599–1614
doi: 10.1001/jama.2015.12783 pubmed: 26501536 pmcid: 4831582
American College of Surgeons (2016) User Guide for the ACS NSQIP Participant Use Data File (PUF). https://www.facs.org/~/media/files/quality%20programs/nsqip/nsqip_puf_userguide_2016.ashx . Accessed 11 Marh 2019
Meguid RA, Bronsert MR, Juarez-Colunga E, Hammermeister KE, Henderson WG (2016) Surgical Risk Preoperative Assessment System (SURPAS): I. Parsimonious, clinically meaningful groups of postoperative complications by factor analysis. Ann Surg 263:1042–1048
doi: 10.1097/SLA.0000000000001669 pubmed: 26954897
McCarthy CM, Mehrara BJ, Riedel E et al (2008) Predicting complications following expander/implant breast reconstruction: an outcomes analysis based on preoperative clinical risk. Plast Reconstr Surg 121:1886–1892
doi: 10.1097/PRS.0b013e31817151c4 pubmed: 18520873
Sinha I, Pusic AL, Wilkins EG et al (2017) Late surgical-site infection in immediate implant-based breast reconstruction. Plast Reconstr Surg 139:20–28
doi: 10.1097/PRS.0000000000002839 pubmed: 28027221 pmcid: 5675129
Carminati M, Sempf D, Bonfirraro PP et al (2018) Immediate implant-based breast reconstruction with acellular dermal matrix compared with tissue-expander breast reconstruction: rate of infection. Plast Reconstr Surg Glob Open 6:e1949
doi: 10.1097/GOX.0000000000001949 pubmed: 30656095 pmcid: 6326629
Throckmorton AD, Boughey JC, Boostrom SY et al (2009) Postoperative prophylactic antibiotics and surgical site infection rates in breast surgery patients. Ann Surg Oncol 16:2464–2469
doi: 10.1245/s10434-009-0542-1 pubmed: 19506959
Massenburg BB, Sanati-Mehrizy P, Ingargiola MJ, Rosa JH, Taub PJ (2015) Flap failure and wound complications in autologous breast reconstruction: a national perspective. Aesthetic Plast Surg 39:902–909
doi: 10.1007/s00266-015-0575-8 pubmed: 26487657
Sorensen LT, Horby J, Friis E, Pilsgaard B, Jorgensen T (2002) Smoking as a risk factor for wound healing and infection in breast cancer surgery. Eur J Surg Oncol 28:815–820
doi: 10.1053/ejso.2002.1308 pubmed: 12477471
Bertin ML, Crowe J, Gordon SM (1998) Determinants of surgical site infection after breast surgery. Am J Infect Control 26:61–65
doi: 10.1016/S0196-6553(98)70062-8 pubmed: 9503114
Hart A, Funderburk CD, Chu CK et al (2017) The impact of diabetes mellitus on wound healing in breast reconstruction. Ann Plast Surg 78:260–263
doi: 10.1097/SAP.0000000000000881 pubmed: 27505449
de Blacam C, Ogunleye AA, Momoh AO et al (2012) High body mass index and smoking predict morbidity in breast cancer surgery: a multivariate analysis of 26,988 patients from the national surgical quality improvement program database. Ann Surg 255:551–555
doi: 10.1097/SLA.0b013e318246c294 pubmed: 22330036
Bergey M, Kovach S, Selber J, Serletti J, Sonnad S, Wu L (2009) Free flap breast reconstruction in advanced age: is it safe? Plast Reconstr Surg 124:1015–1022
doi: 10.1097/PRS.0b013e3181b453fd pubmed: 19935283
Angarita FA, Acuna SA, Cordeiro E et al (2018) Thirty-day postoperative morbidity and mortality in elderly women with breast cancer: an analysis of the NSQIP database. Breast Cancer Res Treat 170:373–379
doi: 10.1007/s10549-018-4747-5 pubmed: 29546481
Noda S, Eberlein TJ, Eriksson E (1994) Breast reconstruction. Cancer 74:376–380
doi: 10.1002/cncr.2820741325 pubmed: 8004611
Disa JJ, Ad-El DD, Cohen SM, Cordeiro PG, Hidalgo DA (1999) The premature removal of tissue expanders in breast reconstruction. Plast Reconstr Surg 104:1662–1665
doi: 10.1097/00006534-199911000-00008 pubmed: 10541166
Rifkin WJ, Kantar RS, Cammarata MJ et al (2019) Impact of diabetes on 30-day complications in mastectomy and implant-based breast reconstruction. J Surg Res 235:148–159
doi: 10.1016/j.jss.2018.09.063 pubmed: 30691788
Fischer JP, Wes AM, Tuggle CT 3rd, Serletti JM, Wu LC (2013) Risk analysis of early implant loss after immediate breast reconstruction: a review of 14,585 patients. J Am Coll Surg 217:983–990
doi: 10.1016/j.jamcollsurg.2013.07.389 pubmed: 23973103
Fischer JP, Nelson JA, Serletti JM, Wu LC (2013) Peri-operative risk factors associated with early tissue expander (TE) loss following immediate breast reconstruction (IBR): a review of 9305 patients from the 2005-2010 ACS-NSQIP datasets. J Plast Reconstr Aesthet Surg 66:1504–1512
doi: 10.1016/j.bjps.2013.06.030 pubmed: 23845908
Piper ML, Roussel L, Koltz PF et al (2017) Characterizing infections in prosthetic breast reconstruction: a validity assessment of national health databases. J Plast Reconstr Aesthet Surg 70:1345–1353
doi: 10.1016/j.bjps.2017.05.004 pubmed: 28619483

Auteurs

Fernando A Angarita (FA)

Division of General Surgery, Department of Surgery, University of Toronto, Toronto, ON, Canada.

Fahima Dossa (F)

Division of General Surgery, Department of Surgery, University of Toronto, Toronto, ON, Canada.
Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada.

Jesse Zuckerman (J)

Division of General Surgery, Department of Surgery, University of Toronto, Toronto, ON, Canada.

David R McCready (DR)

Division of General Surgery, Department of Surgery, University of Toronto, Toronto, ON, Canada.
Department of Surgical Oncology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.

Tulin D Cil (TD)

Division of General Surgery, Department of Surgery, University of Toronto, Toronto, ON, Canada. Tulin.Cil@uhn.ca.
Department of Surgical Oncology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada. Tulin.Cil@uhn.ca.
Department of Surgery, Women's College Hospital, Toronto, ON, Canada. Tulin.Cil@uhn.ca.
Division of General Surgery, University Health Network, 610 University Ave, OPG- 6th Floor, Toronto, ON, M5G 2M9, Canada. Tulin.Cil@uhn.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH